stars 1 stars 2 stars 3

Probitas Pharma is a Spanish holding company specializing in the healthcare pharmaceutical industry. In addition to producing serums, it focuses its activities on the research, development, manufacture and distribution of plasma derivatives, enteral nutrition, reagents, instruments for laboratory tests and medical devices. Probitas Pharma is one of the five major producers of plasma blood products in the world and has an important research and development area. Probitas Pharma also enjoys a reputation for the quality and high level of safety of all its products and services on a worldwide scale. The turnover for Probitas Pharma in the 2002 fiscal year was 390 million Euros, showing a 26.2% increase compared to 2001. The net profit was 18.9 million Euros, representing growth of 88.5% when compared to the previous year. In 2002, all its different business lines experienced significant growth. It is worth highlighting the "Hospital" Division which covers, amongst others, serums contained in both glass and plastic, and which recorded an 8.4% growth, with a sales turnover of over 48 million Euros last year.

Probitas Pharma Questions

The Probitas Pharma annual revenue was $5.8 million in 2026.

Probitas Pharma is based in Cambridge, Cambridgeshire.

The NAICS codes for Probitas Pharma are [32, 32541, 3254, 325].

The SIC codes for Probitas Pharma are [2834, 283, 28].

G2 Leader Summer 2026 G2 Best Est ROI Mid-Market Summer 2026 G2 Easiest Admin Mid-Market Summer 2026 G2 Most Implementable Summer 2026 G2 Best Results Mid-Market Summer 2026 G2 Lead Capture Mid-Market Summer 2026 Inc Fastest Growing Private Companies 2026 Inc Best Workplace 2026
g2crowd
G2Crowd Trusted
chromestore
300K+ Plugin Users